Clinical trial
Concomitant Radiotherapy and Erlotinib in Advanced Lung Cancer
NCT02714530 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Concomitant Radiotherapy and Erlotinib in Advanced Lung Cancer
- Lead sponsor
- Oslo University Hospital
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- April 1, 2014
- Completion date
- December 30, 2020
- Enrollment
- 118 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cancer